These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 34724666)

  • 21. Cannabinoids for symptom management in children with cancer: A systematic review and meta-analysis.
    Chhabra M; Ben-Eltriki M; Paul A; Lê ML; Herbert A; Oberoi S; Bradford N; Bowers A; Rassekh SR; Kelly LE
    Cancer; 2023 Nov; 129(22):3656-3670. PubMed ID: 37635461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid hyperemesis.
    Sullivan S
    Can J Gastroenterol; 2010 May; 24(5):284-5. PubMed ID: 20485701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid hyperemesis syndrome co-occurring with superior mesenteric artery syndrome in adolescents.
    Shanker AI; Li BUK; Kramer RE
    J Pediatr Gastroenterol Nutr; 2024 Jul; ():. PubMed ID: 38994677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabis-Induced Gastrointestinal Tract Symptoms in the Adult Population: A Systematic Review.
    Senderovich H; Meaney C; Vashishtha S
    Med Princ Pract; 2024; 33(2):90-101. PubMed ID: 38198773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Review of Cannabis in Chronic Kidney Disease Symptom Management.
    Ho C; Martinusen D; Lo C
    Can J Kidney Health Dis; 2019; 6():2054358119828391. PubMed ID: 30828459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study.
    Shah M; Jergel A; George RP; Jenkins E; Bashaw H
    J Pediatr; 2024 Aug; 271():114054. PubMed ID: 38615942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis use and cyclical vomiting syndrome: An open debate.
    Kilani Y; Aljabiri Y; Arshad I; Alsakarneh S; Aldiabat M; Castro Puello P; Vahanyan A; Vikash F; Kumar V; Numan L; Thor S
    Dig Liver Dis; 2024 Feb; 56(2):272-280. PubMed ID: 37880016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based Treatment Options in Cannabis Dependency.
    Walther L; Gantner A; Heinz A; Majić T
    Dtsch Arztebl Int; 2016 Sep; 113(39):653-659. PubMed ID: 27776623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RCEM best practice guideline: suspected cannabinoid hyperemesis syndrome in emergency departments.
    Humphries C; Gillings M
    Emerg Med J; 2024 Apr; 41(5):328-331. PubMed ID: 38448215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis use in the United States and its impact on gastrointestinal health.
    Alshaarawy O; Balasubramanian G; Venkatesan T
    Nutr Clin Pract; 2024 Apr; 39(2):281-292. PubMed ID: 38142306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Routes of administration, reasons for use, and approved indications of medical cannabis in oncology: a scoping review.
    Vinette B; Côté J; El-Akhras A; Mrad H; Chicoine G; Bilodeau K
    BMC Cancer; 2022 Mar; 22(1):319. PubMed ID: 35331185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis Hyperemesis Syndrome in a Recently Abstinent Chronic User: Assessment and Intervention.
    Ei Sherif Y; Gouher S; Abualhab MM; El-Khoury J
    Consort Psychiatr; 2024; 5(1):27-32. PubMed ID: 39023110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid hyperemesis syndrome in the pregnant patient: clinical case and literature review.
    Flament J; Scius N; Thonon H
    Int J Emerg Med; 2020 Oct; 13(1):52. PubMed ID: 33115404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019).
    Cameron EC; Hemingway SL
    J Cannabis Res; 2020 May; 2(1):19. PubMed ID: 33526114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cannabinoid hyperemesis syndrome presenting with ventricular bigeminy.
    Wong J; Gill M; Stead T; Huang D; Ganti L
    J Cannabis Res; 2023 Oct; 5(1):36. PubMed ID: 37858157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution.
    Echeverria-Villalobos M; Guevara Y; Mitchell J; Ryskamp D; Conner J; Bush M; Periel L; Uribe A; Weaver TE
    Front Cardiovasc Med; 2024; 11():1343549. PubMed ID: 38978789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive and Antifibrotic Properties of Cannabinoids and Applications to Vasospastic/Vaso-Occlusive Disorders: A Systematic Review.
    Li G; Choi J; Stephens KL; DeGeorge BR
    Ann Plast Surg; 2024 Jun; 92(6S Suppl 4):S445-S452. PubMed ID: 38857012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclic vomiting syndrome: Future clinical and research priorities for: Special supplement/proceedings of 3rd international symposium.
    Hasler WL; Li BUK; Levinthal DJ; Venkatesan T
    Neurogastroenterol Motil; 2024 May; ():e14825. PubMed ID: 38775195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis Hyperemesis Syndrome Recovers Completely When the Use of Cannabis or Synthetic Cannabinoids Is Permanently Discontinued-Cyclic Vomiting Syndrome Does Not.
    Bonnet U
    Gastroenterology; 2024 Jun; ():. PubMed ID: 38945497
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of cannabinoids for acute postoperative pain.
    Sanchis Veryser CA; Esparza Miñana JM; Català Ripoll JV
    Rev Esp Anestesiol Reanim (Engl Ed); 2024 May; ():. PubMed ID: 38801917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.